Caixabank SA (0ILK)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 11.69 |
|---|---|
| 52-week range | 8.34 – 13.56 |
| Return, 1 month / 3 months | −10.0% / −9.5% |
| Return, 1 year / 3 years | +36.9% / +263.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 33 |
| Volatility (1 year) | 26.4% |
| Worst drawdown (1 year) | -15.2% |
| Average daily value traded | 18.16M EUR |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CaixaBank is a Spanish bank based in Valencia that provides retail and commercial banking services. It offers current and savings accounts, mortgages, consumer loans, cards, insurance and investment products to individual customers, and supplies financing, cash management and advisory services to small and medium enterprises and larger corporations. Its branch network and digital channels serve customers mainly in Spain and Portugal, and it also operates in other European markets through specialised banking and insurance activities.
Caixabank SA trades under the code 0ILK on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Caixabank SA (0ILK) trades on the London Exchange in UK. It last closed at EUR 11.69 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 635 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 36.9% and over the last three months it fell 9.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.5% | ||
| From 52-week high | -13.2% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -9.5% | ||
| 6-month return | 8.3% | ||
| 12-month return, skipping the last month | 52.2% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.2% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 18.16M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 58 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.2% |
|---|---|
| 1 month | −10.0% |
| 3 months | −9.5% |
| 6 months | +8.3% |
| 1 year | +36.9% |
| 3 years | +263.4% |
| 5 years | +468.6% |
Signals
| 50-day / 200-day average | 12.78 / 11.51 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.28 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Apr 2026 | EUR 0.2690 |
| 5 Nov 2025 | EUR 0.1360 |
| 22 Apr 2025 | EUR 0.2320 |
| 5 Nov 2024 | EUR 0.1205 |
| 28 Mar 2024 | EUR 0.3174 |
| 6 Apr 2023 | EUR 0.1868 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.